Securing patent rights and funding in the US – a primer for start-ups and other small entities

For most start-ups and SMEs, the US represents not only a large but also a very important market. The US also offers a significant source of potential funding. From a patenting perspective, the US is known as the jurisdiction where patent applicants get the most bang for their buck. US patents are generally necessary to secure funding in the US.

The presentation will cover what is important for start-ups and SMEs when building IP assets and preparing to approach investors in the US. We will discuss what is critical and needs to be considered prior to starting the creation of these IP assets. What should be included in US patent applications to maximise IP protection, and what are the possibilities at the USPTO? Depending on the field, regulatory aspects may also need to be taken into account. What are the alternatives, and what are the consequences? What needs to be prepared before approaching an investor, and how can the right investor be found? The audience will have the opportunity to have their individual questions answered.

Three Takeaways

• Patent applicants get the most bang for their buck in the US.
• Funding from US investors relies heavily on issued US patents.
• Certain IP strategies can help facilitate allowance of patent claims.

Speakers

• Erik Krahbichler, European Patent Attorney and founder of KIPA with a solid background in the field of medical device technology.
• Gabriela Tomescu, US Patent Attorney, Attorney at Law, with extensive experience working with start-ups and SMEs in the Bay Area in California.

About KIPA

KIPA is an IP law firm with highly experienced attorneys, all of whom have in-house experience from both large and SME companies. We support and assist from the early stages of a companys journey in any IP matter and have a vast network of other experts who may be needed during product development. KIPA AB is present at Medicon Village, with its head office in Helsingborg.

2024 KIPA AB has expanded and enlarged the Life Science Team to cover more technical fields after demands from the clients. One Canadian Patent Attorney and one US Patent Attorney. In addition, a European Patent Attorney Anna Johnson Aspberg has joined us. To support the team a new paralegal has also been onboarded, Come and meet us all.